Zobrazeno 1 - 10 of 14 pro vyhledávání: '"D R Gretch"'
1
Recombinant immunoblot and polymerase chain reaction testing in volunteer whole blood donors screened by a multi-antigen assay for hepatitis C virus antibodies
Autor: Merlyn H. Sayers, D. R. Gretch
Publikováno v: Transfusion. 33:809-813
The purpose of this study was to compare the results of supplementary testing of volunteer whole blood donors who had been screened by the first hepatitis C virus antibody assay licensed in the United States with results from donors screened by a new
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e84eb90299ba09dd74b48d0db078060
https://doi.org/10.1046/j.1537-2995.1993.331094054616.x
Zobrazit plný text záznamu
2
Laboratory approaches to the diagnosis of hepatitis C virus infection
Autor: K R, Jerome, D R, Gretch
Publikováno v: Minerva gastroenterologica e dietologica. 50(1)
Hepatitis C virus (HCV) infection is a major and growing health problem worldwide. Laboratory testing plays an important role in the response to the HCV epidemic. Serologic tests for antibody to HCV are useful for screening purposes. The mainstays of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa8b844d393f170227a04b11d555516b
https://pubmed.ncbi.nlm.nih.gov/15719002
Zobrazit plný text záznamu
3
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests
Autor: D R, Dufour, J A, Lott, F S, Nolte, D R, Gretch, R S, Koff, L B, Seeff
Publikováno v: Clinical chemistry. 46(12)
To review information on performance characteristics for tests that are commonly used to identify acute and chronic hepatic injury.A MEDLINE search was performed for key words related to hepatic tests, including quality specifications, aminotransfera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da1539173c8ac73a10d5f8c11d500914
https://pubmed.ncbi.nlm.nih.gov/11375313
Zobrazit plný text záznamu
4
Molecular tools for the treatment of hepatitis C
Autor: J M, Pawlotsky, D R, Gretch
Publikováno v: Antiviral therapy. 3(Suppl 3)
The treatment of chronic hepatitis C is aimed at eliminating viral replication in order to prevent further evolution towards cirrhosis and hepatocellular carcinoma. Virological parameters include hepatitis C virus (HCV) genotype, qualitative viraemia
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e1d4489e5d1174c94a067de5ec43c9f6
https://pubmed.ncbi.nlm.nih.gov/10726055
Zobrazit plný text záznamu
5
Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury
Autor: H R, Rosen, D R, Gretch, M, Oehlke, K D, Flora, K G, Benner, J M, Rabkin, C L, Corless
Publikováno v: Transplantation. 65(9)
The majority of patients infected with hepatitis C virus (HCV) undergoing liver transplantation develop evidence of histologic recurrence, and multiple mechanisms are likely poised to affect long-term allograft injury. The purpose of this analysis wa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5913d3695b7623620207b10d8714063d
https://pubmed.ncbi.nlm.nih.gov/9603164
Zobrazit plný text záznamu
6
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
Autor: W T, Hofgärtner, S J, Polyak, D G, Sullivan, R L, Carithers, D R, Gretch
Publikováno v: Journal of medical virology. 53(2)
Previous studies from Japan have described an association between a conserved sequence within the hepatitis C virus (HCV) genome and resistance to interferon (IFN) therapy for patients infected with HCV genotype 1b [Enomoto et al. (1995): Journal of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::69b6f1e9603e29d62d2e7798ad456eb2
https://pubmed.ncbi.nlm.nih.gov/9334922
Zobrazit plný text záznamu
7
Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C
Autor: H R, Rosen, S, Chou, C L, Corless, D R, Gretch, K D, Flora, A, Boudousquie, S L, Orloff, J M, Rabkin, K G, Benner
Publikováno v: Transplantation. 64(5)
Despite recent advances in diagnosis and treatment, cytomegalovirus (CMV) infection continues to be a common cause of morbidity in liver transplant (LT) recipients. Because CMV infection suppresses cell-mediated immunity, which seems to be important
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::427c3dcb2ead1990446657109547f369
https://pubmed.ncbi.nlm.nih.gov/9311709
Zobrazit plný text záznamu
10
Hepatitis B and transplantation
Autor: C L, Davis, D R, Gretch, R L, Carithers
Publikováno v: Infectious disease clinics of North America. 9(4)
Hepatitis B infection can add significantly to the morbidity and mortality of transplantation. Patients with hepatitis B can have severe recurrent disease following liver transplantation. Reactivation of occult disease can occur during chemotherapy o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e71db5015f04bd83f6a55bce495f8e9
https://pubmed.ncbi.nlm.nih.gov/8747773
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje